Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study

• by Shungo Yamamoto, Akihiro Shiroshita, Yuki Kataoka, Hidehiro Someko

• March 5, 2025

Epitope Conservation of AZD5148, a Broadly Neutralizing Anti-Toxin B Monoclonal Antibody, Among Diverse and Global Contemporary Clostridioides difficile Isolates

• by Kelly Ann Mahool, Emily Nguyen, Victoria Godfrey, Ann Marie Stanley, Tyler Brady, Adam Gamson, Kim Rosenthal, Justin Green, Ondrej Podlaha, Bret R Sellman, Christine Tkaczyk, Vancheswaran Gopalakrishnan

• August 14, 2025

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min